日本全国问卷调查评估红曲片相关肾损伤
该研究通过两阶段全国问卷调查日本肾内科医生,分析红曲片相关肾损伤患者的临床、实验室及病理特征。192例患者中94.1%表现为eGFR低于60 ml/min/1.73m2,实验室检查呈Fanconi综合征特征,肾活检以肾小管间质病变为主;停用产品并治疗后Fanconi综合征相关指标改善,但87%患者末次观察时eGFR仍低于60 ml/min/1.73m2。
要点
- 红曲片相关肾损伤多表现为低eGFR和Fanconi综合征特征。
- 肾活检以肾小管间质病变为主,肾小球改变不明显。
- 停用产品后Fanconi综合征指标改善,但多数患者eGFR仍低于60。
核心结论
- 红曲片相关肾损伤以肾小管间质病变和Fanconi综合征为特征,停用产品后部分指标改善但多数患者eGFR仍低于60 ml/min/1.73m2,需长期随访。
研究设计与样本
- 两阶段全国问卷调查日本肾内科医生,初始调查收集临床表现,随访调查追踪肾功能变化并收集病理数据。
- 共纳入192例患者。
- 统计分析包括按eGFR分层的趋势评估和eGFR轨迹的混合效应模型。
主要发现
- 192例患者中94.1%表现为低eGFR(低于60 ml/min/1.73m2)。
- 实验室检查显示Fanconi综合征特征,包括低钾血症、低磷血症、低尿酸血症、糖尿和代谢性酸中毒。
- 肌酸激酶水平未升高,提示无横纹肌溶解相关肾损伤。
- 肾活检显示以肾小管间质改变为主,50%为肾小管间质性肾炎,32%为肾小管坏死,肾小球改变不明显。
- 停用产品并治疗后Fanconi综合征相关参数显著改善,但87%患者末次观察时eGFR仍低于60 ml/min/1.73m2。
临床怎么用
- 对服用红曲片者应监测肾功能和Fanconi综合征相关指标。
- 疑似病例应停用产品并考虑肾活检明确病理类型。
- 即使停用产品后指标改善,仍需长期随访肾功能。
局限性
- 研究为问卷调查,需进一步研究确立 definitive 因果关系和长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Red yeast rice, traditionally used in Asian cuisine and increasingly marketed as a dietary supplement for cholesterol management, has recently been linked to kidney dysfunction in Japan. In late 2023 to early 2024, multiple cases involving specific Beni-koji (red yeast rice) tablets from three different Beni-koji preparations, prompted a safety reevaluation. Although citrinin, a known nephrotoxin of red yeast rice, was not produced by the implicated strains, new safety concerns emerged. Here, we aimed to investigate the clinical, laboratory, and pathological features of affected patients with a two-phase nationwide survey of Japanese nephrologists. The initial survey captured clinical presentations, while the follow-up survey tracked changes in kidney function and gathered pathological data. Statistical analyses included trend assessments across estimated glomerular filtration rate (eGFR) categories and mixed-effects models for eGFR trajectories. Of 192 patients, 94.1% presented with low eGFR (under 60 ml/min/1.73m2). Laboratory findings revealed characteristics of Fanconi syndrome, including hypokalemia, hypophosphatemia, hypouricemia, glycosuria, and metabolic acidosis. Creatine kinase levels were not elevated suggesting no rhabdomyolysis related kidney injury. Kidney biopsies showed predominant tubulointerstitial changes, with 50% exhibiting tubulointerstitial nephritis and 32% showing tubular necrosis. Glomerular changes were less prominent. Following product discontinuation and treatment, Fanconi syndrome-related parameters improved significantly. However, 87% of patients still had eGFR under 60 ml/min/1.73m2 at the last observation. Our findings underscore the need for long-term follow-up of affected individuals and highlight the importance of rigorous safety evaluations for dietary supplements. Further research is necessary to establish definitive causal relationships and long-term outcomes.
引用
- Shinzawa M, Matsui I, Doi Y, et al. A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in Japan. Kidney Int. 2024. PMID: 39708997. doi:10.1016/j.kint.2024.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。